These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29853493)

  • 1. Should reversibility be assessed in all asthmatic children with normal spirometry?
    Dufetelle E; Bokov P; Delclaux C; Beydon N
    Eur Respir J; 2018 Aug; 52(2):. PubMed ID: 29853493
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma.
    Bussamra MH; Cukier A; Stelmach R; Rodrigues JC
    Chest; 2005 Feb; 127(2):530-5. PubMed ID: 15705992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol.
    Lipworth BJ; Jackson CM
    Chest; 2002 Apr; 121(4):1382. PubMed ID: 11948092
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of lung volume measurements by plethysmography in the follow-up of asthma in children].
    Labbé G; Merlin E; Kauffman C; Fauquert JL; Héraud MC; Labbé A
    Rev Mal Respir; 2010; 27(1):42-8. PubMed ID: 20146951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levalbuterol kinetics.
    Lipworth BJ; Clearie K
    J Allergy Clin Immunol; 2009 Jan; 123(1):275. PubMed ID: 19130946
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical significance of the bronchodilator response in children with severe asthma.
    Coverstone AM; Bacharier LB; Wilson BS; Fitzpatrick AM; Teague WG; Phipatanakul W; Wenzel SE; Gaston BM; Bleecker ER; Moore WC; Ramratnam S; Jarjour NN; Ly NP; Fahy JV; Mauger DT; Schechtman KB; Yin-DeClue H; Boomer JS; Castro M
    Pediatr Pulmonol; 2019 Nov; 54(11):1694-1703. PubMed ID: 31424170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of time on the perception of dyspnea following inhaled long-acting bronchodilator].
    Weiner P; Magadle R; Beckerman M; Berar-Yanay N
    Harefuah; 2003 May; 142(5):342-4, 398. PubMed ID: 12803056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response characteristics of nebulized albuterol in the treatment of acutely ill, hospitalized asthmatics.
    Ciccolella DE; Brennan K; Kelsen SG; Criner GJ
    J Asthma; 1999 Sep; 36(6):539-46. PubMed ID: 10498049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do fixed combinations increase effectiveness in asthma bronchiale?].
    Vogelmeier C
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S372-5. PubMed ID: 19941239
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized Clinical Trial Comparing Breath-Enhanced to Conventional Nebulizers in the Treatment of Children with Acute Asthma.
    Gardiner MA; Wilkinson MH
    J Pediatr; 2019 Jan; 204():245-249.e2. PubMed ID: 30392872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
    Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
    Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility after inhaling salbutamol in different body postures in asthmatic children: a pilot study.
    Visser R; van der Palen J; de Jongh FH; Thio BJ
    Respir Med; 2015 Apr; 109(4):459-62. PubMed ID: 25727243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of airway responsiveness using colored three-dimensional analyses of a new forced oscillation technique in controlled asthmatic and nonasthmatic children.
    Murakami K; Habukawa C; Kurosawa H; Takemura T
    Respir Investig; 2014 Jan; 52(1):57-64. PubMed ID: 24388372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].
    Virchow C
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240
    [No Abstract]   [Full Text] [Related]  

  • 15. Determining the time to maximal bronchodilator response in asthmatic children.
    Stavreska V; Verheggen M; Oostryck J; Stick SM; Hall GL
    J Asthma; 2009 Feb; 46(1):25-9. PubMed ID: 19191133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial.
    Nuijsink M; Hop WC; Sterk PJ; Duiverman EJ; de Jongste JC
    Eur Respir J; 2007 Sep; 30(3):457-66. PubMed ID: 17537770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility of pulmonary function after inhaling salbutamol in different doses and body postures in asthmatic children.
    Visser R; Kelderman S; de Jongh FH; van der Palen J; Thio BJ
    Respir Med; 2015 Oct; 109(10):1274-9. PubMed ID: 26341548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of long-term treatment with HFA albuterol.
    Ramsdell JW; Klinger NM; Ekholm BP; Colice GL
    Chest; 1999 Apr; 115(4):945-51. PubMed ID: 10208190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates.
    Newhouse MT; Nantel NP; Chambers CB; Pratt B; Parry-Billings M
    Chest; 1999 Apr; 115(4):952-6. PubMed ID: 10208191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
    Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
    Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.